ImmunologybioRxivPreprint
Mettl3-catalyzed m6A methylation determines CD8+ T cell differentiation fate in tumor
Puspendu Ghosh, Anupam Gautam, Debashree Basak…·Shilpak Chatterjee
This study identifies Mettl3-m6A methylation as a regulator of CD8+ T cell differentiation fate in tumors, showing its role in promoting terminal exhaustion and its potential as a target to enhance immunotherapy.